Hydrogen Bromide → HCID 66732613, compound
Reaction equation
[O:1]=[C:2]1[CH:6]=[C:5]([C@H:7]2[CH2:12][CH2:11][N:10](C(OC)=O)[C@@H:9]([CH2:17][C:18]3[CH:23]=[C:22]([F:24])[C:21]([F:25])=[C:20]([F:26])[CH:19]=3)[CH2:8]2)[O:4][NH:3]1.Br>>[F:26][C:20]1[CH:19]=[C:18]([CH:23]=[C:22]([F:24])[C:21]=1[F:25])[CH2:17][C@H:9]1[CH2:8][C@@H:7]([C:5]2[O:4][NH:3][C:2](=[O:1])[CH:6]=2)[CH2:12][CH2:11][NH:10]1Participants
3
Procedure
(2R,4S)-Methyl 4-(3-oxo-2,3-dihydroisoxazol-5-yl)-2-(3,4,5-trifluorobenzyl)piperidine-1-carboxylate (584 mg, 1.58 mmol) was dissolved in hydrogen bromide (33% in AcOH, 7 mL, 302.80 mmol) and stirred at room temperature for 20 h. The solvent was evaporated and the residue purified by preparative HPLC (Instrument: FractionLynx II, Mobilphase: gradient 5-95% MeCN in 0.2% NH3, pH 10, Column: Xbridge Prep C18 5 μm OBD 19*150 mm) to yield 5-((2R,4S)-2-(3,4,5-trifluorobenzyl)piperidin-4-yl)isoxazol-3(2H)-one (325 mg, 66%). 1H NMR (600 MHz, dmso) δ 1.05 (q, 1H), 1.31 (dq, 1H), 1.71-1.78 (m, 2H), 2.34-3.78 (m, 6H), 5.68 (s, 1H), 7.12-7.20 (m, 2H). HRMS Calculated for [C15H15F3N2O2+H]+: 313.1164. Found: 313.1172
Workup
- customThe solvent was evaporated
- customthe residue purified by preparative HPLC (Instrument: FractionLynx II, Mobilphase: gradient 5-95% MeCN in 0.2% NH3, pH 10, Column: Xbridge Prep C18 5 μm OBD 19*150 mm)
Sources & evidence
- ORD record
- ord-065fda1ed24b4c5aae47c65a73ca0b15
- Source dataset
- uspto-grants-2013_04
- Patent number
- US08415378B2
Reaction notes
Loading…